CMPS COMPASS Pathways Plc - American
$14.35▲ +0.91%
Healthcare
Other
After hours
$14.26▼ -0.63%
Sep 11, 7:49 PM ET
Volume 2.01M
Avg Volume (10D) 2.69M
Key Metrics & Fundamentals
Market Cap
$1.99B
P/E Ratio
–
Div Yield
–%
52W Range
4.82 - 15.87
% vs 50 MA
9.31%
% vs 200 MA
53.54%
RSI-14
56.1
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.41
Free Cash Flow
-$40.31M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$45.50M
COGS
–
Operating Exp
$49.79M
Operating Income
-$49.79M
EBIT
-$49.79M
Pretax Income
-$253.46M
Net Income
-$253.79M
EPS (Diluted)
-1.88
Price & Volume History
Loading chart…
Recent News
Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
Business Wire · Sep 11, 2026 8:10 PM
Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
PR Newswire · Sep 10, 2026 12:00 PM
Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
Business Wire · Sep 10, 2026 10:35 AM
Compass Pathways to Participate in Investor Conferences the Week of September 14th
Business Wire · Sep 10, 2026 10:30 AM
Compass Pathways stock rises as 52-week data show lasting depression relief
Proactive · Sep 9, 2026 4:19 PM
CMPS Stock Defies Market Selloff After Compass Pathways Psilocybin Trial Success Pointing To 2027 Launch
Stocktwits · Sep 9, 2026 2:06 PM
Compass Pathways reports 52-week Phase 3 COMP005 results for COMP360
InvestorsHub · Sep 9, 2026 12:48 PM
Wall Street slips for a third straight day as oil and yields climb
Proactive · Sep 9, 2026 11:56 AM
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
Business Wire · Sep 9, 2026 10:30 AM
CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing
Stocktwits · Sep 8, 2026 10:28 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CMPS's money flow as a full page
Social Sentiment
Avg +0.82 · 18 posts
DDNewsPriceTarget$CMPS Compass Pathways: A Structural Mispricing in Plain Sight?
r/wallstreetbets · Jul 13, 2026
The author highlights strong fundamentals and a mispriced stock, indicating a bullish view.
positive
+0.80
DDNewsDiscussionTradeMemeCMPS: Synthetic psyclobin nearing FDA approval
r/wallstreetbets · Jul 10, 2026
Strong bullish sentiment due to FDA approval progress, Phase 3 success, and a key investor's involvement.
very_positive
+1.00
DDNewsDiscussionTradeMemeCMPS: the FDA-stage shroom bet with actual Phase 3 data a.k.a shrooms to the moon
r/wallstreetbets · Jul 10, 2026
Strong bullish sentiment expressed due to Phase 3 trial results, FDA designation, and potential for significant upside.
very_positive
+1.00
DiscussionTradeGamble?
r/wallstreetbets · Jul 8, 2026
The user's gains and desire to hold suggest optimism about CMPS performance.
positive
+0.60
PriceTargetNewsDiscussionCMPS to $40 Is Starting to Look Very Real
r/wallstreetbets · May 14, 2026
The post expresses optimism about CMPS's future and potential, reflecting a bullish sentiment.
positive
+0.70
Page 1 of 4 (18 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.